1st Quarter - Report

EMPIRE CONSULTING GROUP for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 1227, Alternatives to PAIN Act; issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.

LobbyistCovered position, as disclosed
E. BRANDON GARRETT —
BRIAN GREER —
MIKE MCKAY —
MIKE P MULLEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1227 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.